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Defective NK Cell Activity and Th1 Response
in IL-18±Deficient Mice
Thus, IL-18 apparently shares its biological functions
with IL-12, which is known to have immunoregulatory
activities, including the induction of IFNg production,
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(Okamura et al., 1995b; Ushio et al., 1996). In spite ofHyogo College of Medicine
the biological functions it shares with IL-12, the amino1±1 Mukogawa-cho, Nishinomiya
acid sequence of IL-18 has no similarity with that of IL-Hyogo 663
12. Interestingly, a three-dimensional homology searchJapan
revealed that IL-18 has a striking similarity to the IL-1§Research Institute
family of cytokines (Bazan et al., 1996). IL-18 is synthe-Osaka Maternal and Child Health Center
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cleavage at the site of the aspartate residue (Okamura etOsaka 590±02
al., 1995b; Ushio et al., 1996). Interleukin-1b convertingJapan
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for converting the precursor of IL-1b into the mature IL-2±2 Yamada-oka, Suita
1b (Cerretti et al., 1992; Thornberry et al., 1992). Re-Osaka 565
cently, it has been demonstrated that ICE also cleavesJapan
the precursor of IL-18 into the mature form (Ghayur et
al., 1997; Gu et al., 1997). Furthermore, the receptor for
IL-18 was recently identified (Torigoe et al., 1997). ThisSummary
molecule is identical to the molecule designated as the
IL-1 receptor±related protein (IL-1Rrp), which has a re-IL-18 is a cytokine that is secretedfrom activated mac-
semblance to the type 1 IL-1 receptor and can transducerophages and induces IFNg production. To investigate
IL-1 signaling (Parnet et al., 1996). In fact, IL-18 inducesthe in vivo role of IL-18, we generated IL-18±deficient
activation of IL-1 receptor±associated kinase and nu-mice. In Propionibacterium acnes (P. acnes)±primed
clear translocation of nuclear factor kB (Matsumoto et
IL-18±deficient mice, LPS-induced IFNg production
al., 1997; Robinson et al., 1997). Thus, IL-18 is similar
was markedly reduced, despite normal IL-12 induc-
to the IL-1 family of cytokines in the molecular mecha-
tion. Natural killer cell activity was significantly im-
nisms of its signaling.
paired. Th1 cell response after injection of P. acnes or IL-18 has other functions in addition to those it shares
Mycobacterium bovis (bacillus Calmette-GueÂrin [BCG]) with IL-12. Treatment of P. acnes±sensitized athymic
was significantly reduced. Similar results were ob- nude mice with anti±IL-18 antibody can prevent LPS-
served in IL-12±deficient mice. Interestingly, Th1 re- induced liver injury, indicating that IL-18 is involved in
sponse was induced after BCG infection in IL-12± the pathogenesis of endotoxin-induced liver injury (Oka-
deficient mice. We therefore generated mice lacking mura et al., 1995b; Tsutsui et al., 1997). IL-18 up-regu-
both IL-18 and IL-12. In these mice, NK activity and lates Fas ligand expression on NK cells (Tsutsui et al.,
Th1 response were further impaired. This demon- 1996). Similarly, IL-18 enhances Fas ligand±mediated
strates the important role of both IL-18 and IL-12 in cytotoxicity of Th1 cells (Dao et al., 1996). IL-18 induces
NK activity, as well as in in vivo Th1 response. IFNg production from anti-CD40 plus IL-4±stimulated B
cells and inhibits Immunoglobulin E production in an
Introduction autocrine manner (Yoshimoto et al., 1997). Additionally,
IL-18 is produced from osteoblasts and inhibits osteo-
Interleukin-18 (IL-18) is a cytokine that was identified in clast formation and is induced in the adrenal cortex
the liver of mice sequentially treated with Propionibacte- under stressful conditions (Conti et al., 1997; Udagawa
rium acnes (P. acnes) and lipopolysaccharide (LPS) et al., 1997).
(Okamura et al., 1995a). This molecule was originally To determine the in vivo functions of IL-18, we gener-
identified as interferong inducing factor (IGIF), a factor ated IL-18±deficient mice by gene targeting. IL-18±
that induces interferong (IFNg) production from spleno- deficient mice displayed reduced production of IFNg,
cytes, liver lymphocytes, and type 1 T helper (Th1) cell impaired NK cell activity, and defective Th1 cell re-
clones (Okamura et al., 1995a, 1995b; Kohno et al., 1997; sponse. Since these defects were not complete, we
Matsui et al., 1997). In addition, IL-18 enhances natural generated mice lacking both IL-18 and IL-12. In mice
killer (NK) cell activity and proliferation of activated T lacking bothcyokines, NK cell activityand Th1 cell differ-
cells (Okamura et al., 1995a, 1995b; Ushio et al., 1996). entiation were further disturbed. These results clearly
demonstrate the importance of in vivo cooperative ac-
tion of IL-18 and IL-12 in NK lytic activity and the Th1# To whom correspondence should be addressed (e-mail: akira@
hyo-med.ac.jp). response.
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fertile (Figure 1B). To confirm that the IL-18 mutation
inactivates the IL-18 gene, IL-182/2 and wild-type mice
were intraperitoneally injected with 500 mg of P. acnes.
At 4 days after injection, peritoneal macrophages were
analyzed for IL-18 expression by Northern blot analysis.
IL-18 mRNA could not be detected in macrophages of
IL-182/2 mice (Figure 1C). Serum IL-18 concentration
1.5 hr after intravenous injection with LPS was analyzed
by enzyme-linked immunosorbent assay (ELISA). In
wild-type mice, increased production of IL-18 was ob-
served. However, in IL-182/2 mice, the serum concentra-
tion of IL-18 was below the detectable level, indicating
that the IL-18 gene mutation leads to no production of
IL-18 (Figure 2A).
Flow cytometric analysis of lymphoid organs showed
that lymphocyte composition was not altered in IL-182/2
mice. However, the intensity of CD3 expression in T cells
from IL-182/2 mice was slightly lower than that in wild-
type mice (data not shown). The dull CD3 expression
was not enhanced by in vitro culture with IL-18, indicat-
Figure 1. Targeted Disruption of the IL-18 Gene ing that CD3 expression was affected during differentia-
(A) Maps of the IL-18 wild-type genome, the targeting construct, tion and maturation of IL-182/2 T cells (data not shown).
and the predicted disrupted gene. Open and closed boxes denote Although CD3 expression was slightly dull in IL-182/2
the non-coding and coding exons, respectively. The neo box repre- T cells, these cells showed almost the same level of
sents the MC-1-neo poly(A)1 gene. The HSV-tk box represents the
proliferative response to anti-CD3 antibody as did wild-herpes simplex virus±thymidine kinase gene. The 0.5 kb fragment
type T cells. Moreover, IL-182/2 T cells proliferated tocorresponding to exon 2 was used as a probe in Southern blot
an almost equal degree in response to IL-2 plus anti-hybridization. Restriction enzymes: B, BamHI; P, PstI.
(B) Southern blot analysis of tail DNA of offspring from the heterozy- CD3 antibody as did wild-type T cells (data not shown).
gote intercrosses. Genomic DNA was extracted from mouse tails, These results indicate that the activation of T cells
digested with PstI, electrophoresed, and hybridized with a probe through CD3 stimulation was not affected in IL-182/2
indicated in (A). This hybridization resulted in the detection of a 5.2
mice, in spite of the slight decrease in expression ofkb band in the wild-type alleles, and a 4.8 kb band in the correctly
CD3.targeted alleles.
(C) Northern blot analysis of macrophages activated by P. acnes.
Mice were intraperitoneally injected with 500 mg of heat-killed P.
Reduced Production of IFNg in IL-182/2 Miceacnes. Four days after injection, peritoneal exudate cells were elic-
We analyzed IFNg production after treatment with LPSited, and cultured for 2 hr. Total RNA was extracted from the adher-
in P. acnes±sensitized mice. Heat-killed P. acnes wasent macrophage monolayers, electrophoresed, transferred to nylon
membrane, and hybridized with the mouse IL-18 cDNA probe. The injected intraperitoneally, and 7 days later LPS was in-
same membrane was rehybridized with a GAPDH probe. jected intravenously. Serum IFNg level was measured 6
hr after LPS challenge. The serum IFNg level in IL-182/2
mice was about one fifth of that in wild-type mice, dem-Results
onstrating the important role of IL-18 in in vivo IFNg
production (Figure 2B). Although IL-12 is known to in-Generation of IL-18±Deficient Mice
duce IFNg, the serum IL-12 level after LPS challenge inWe disrupted the IL-18 gene by homologous recombina-
IL-182/2 mice was almost the same as that in wild-typetion in embryonic day 14.1 embryonic stem cells. The
mice (Figure 2C). This result suggests that the reducedmouse IL-18 genomic DNA consists of five exons and
IFNg production was not secondary to low induction offour introns and is about 20 kb in length. Exon 1 is .10
IL-12.kb away from exon 2. A targeting vector was constructed
to replace a 3.0 kb fragment of genomic DNA containing
exons 3, 4, and 5 with the neomycin-resistance (neo) Impaired NK Cell Activity in IL-182/2 Mice
IL-18 has been shown to augment NK cell activity (Oka-gene (Figure 1A). Embryonic stem cells were transfected
with the linearized targeting vector and selected in the mura et al., 1995a, 1995b; Ushio et al., 1996). We analyzed
the function of NK cells by YAC-1 cell killing activity.presence of G418 and gancyclovir. Homologous recom-
binant clones were screened by polymerase chain reac- Spleen cells were incubated with 51Cr-labeled YAC-1 NK
target cells at the indicated effector/target ratios, andtion. Thirteen correctly targeted clones out of 138 doubly
resistant clones were verified by Southern blot analysis. 51Cr release was measured. The killing activity of NK
cells from IL-182/2 mice was about one third of that fromThree of these targeted clones were microinjected into
C57BL/6 blastocysts to generate chimeric mice. One wild-type mice (Figure 3A). Intraperitoneal administra-
tion of exogenous IL-18 daily for 2 days dramaticallyline of these chimeric mice successfully contributed to
the germline. Heterozygous mice were intercrossed to restored the killing activity of IL-182/2 NK cells. (Figure
3B). More enhanced NK lytic activitywas observed whenobtain mice homozygous for the IL-18 gene mutation. IL-
18±deficient (IL-182/2) mice were born at the expected treated with both IL-18 and IL-12.
Since NK activity in IL-182/2 mice after IL-18 treatmentMendelian ratios and were phenotypically normal and
IL-18 Knockout Mice
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Figure 2. Serum Concentration of IL-18, IFNg,
and IL-12 after LPS Challenge in P. acnes±
Sensitized Mice
Mice were intraperitoneally injected with 500
mg of heat-killed P. acnes. LPS challenge was
7 days after injection.
(A) Sera were taken 1.5 hr after LPS challenge
and analyzed for the production of IL-18 by
ELISA.
(B and C) Sera were taken 6 hr after LPS
challenge and analyzed for the production of
IFNg (B) or IL-12 (C) by ELISA. These data are
the average of three or four mice analyzed.
was higher than that seen in wild-type mice, we exam- in IL-182/2 mice as compared with wild-type mice (Fig-
ure 3C). However, when the dose of IL-12 was increasedined whether expression of the IL-18 receptor IL-1Rrp
was increased in IL-182/2 mice. We performed Northern to 100 ng, NK lytic activity in the IL-182/2 mice was
enhanced to an almost equal degree with that in theblot analysis of spleen cells, using cDNA of the IL-18
receptor as a probe (Figure 3D). Expression of IL-1Rrp wild-type. Taken together, these results demonstrate
that the combined action of IL-18 and IL-12 plays anwas below the detectable level and slightly induced after
P. acnes injection in the splenocytes of wild-type mice. important role in the activation of NK cells, although
administration of a high amount of IL-12 could enhanceIn contrast, abundant expression of IL-1Rrp was ob-
served, and its expression was dramatically enhanced NK activity to the normal level in the absence of IL-18.
after P. acnes injection in splenocytes from IL-182/2
mice. Thus, it is possible that NK cells of IL-182/2 mice Defective Th1 Response in IL-182/2 Mice
Like IL-12, IL-18 is shown to activate Th1 cells and in-are highly responsive to IL-18 because of the increased
expression of the IL-18 receptor. duce IFNg production from these cells (Okamura et al.,
1995a, 1995b; Kohno et al., 1997; Matsui et al., 1997).IL-12 has been shown to enhance NK cell activity
(Gately et al., 1994; Trinchieri, 1994, 1995). Therefore, Recent studies demonstrate that IL-18 does not in itself
drive Th1 development but synergizes with IL-12 forwe next analyzed the effect of IL-12 on NK activity of
IL-182/2 mice. Intraperitoneal administration of 5 ng of production of IFNg from developing Th1 cells, arguing
for the potential role of IL-18 in IL-12±primed Th1 cellIL-12 enhanced NK activity in wild-type mice (Figure
3C). Almost no enhancement of NK lytic activity was development (Matsui et al., 1997; Robinson et al., 1997).
Therefore, we examined Th1 cell development in vivoobserved in IL-182/2 mice after administration of 5 ng
of IL-12. When the dose of IL-12 was increased to 10 using IL-182/2 mice. Mice were intraperitoneally injected
with heat-killed P. acnes, which was previously shownng, the increase in NK activity was still severely reduced
Figure 3. NK Cell Activity in IL-182/2 Mice
(A) Naive spleen cells were analyzed for NK
lytic activity against 51Cr±labeled YAC-1 tar-
get cells. 51Cr±releases in supernatantsof cul-
tures at the indicated effector/target (E/T) ra-
tios were measured.
(B) Mice were intraperitoneally injected with
PBS, 1000 ng of IL-18, or 100 ng of IL-12 and
IL-18 daily for 2 days. On the next to last day
of injection, spleen cells were analyzed for
NK lytic activity. The data are the activity at
a 50/1 E/T ratio.
(C) Mice were intraperitoneally injected with
PBS or 5, 10, or 100 ng of IL-12 daily for
2 days. Spleen cells were analyzed for NK
activity. The data are the activity at a 50/1
E/T ratio.
(D) Expression of the IL-18 receptor in spleen.
Total RNA was extracted from spleens of
noninfected mice (naive) or heat-killed P.
acnes injected mice (P. acnes), electropho-
resed, transferred to nylon membrane, and
hybridized with the mouse IL-18 receptor
cDNA probe.
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Figure 5. NK Cell Activity in IL-122/2 Mice
Wild-type or IL-122/2 mice were intraperitoneally injected with PBS
or 10, 100, or 1000 ng of IL-18 daily for 2 days. On the next to last
day of injection, spleen cells were analyzed for NK lytic activity
against YAC-1 target cells. The data are the activity at 50/1 effector/
target ratio.
(Figure 4C). Similarly, T cells from Nippostrongylus bra-
Figure 4. Th1 Cell Development In Vivo and In Vitro in IL-182/2 Mice siliensis±infected IL-182/2 mice produced almost the
(A) Mice were intraperitoneally injected with 500 mg of heat-killed same level of IL-4 as did wild-type T cells, further sup-
P. acnes. Seven days after injection, splenic T cells were purified porting the normal Th2 response in IL-182/2 mice (dataand stimulated by immobilized anti-CD3 antibody for 24 hr. The
not shown). When stimulated with IL-12 in vitro, IL-182/2concentrations of IFNg in culture supernatants were measured using
T cells produced almost the same level of IFNg as com-ELISA.
(B) Mice were intravenously injected with 2 mg of BCG. Fourteen pared with wild-type T cells (Figure 4D). These results
days after injection, production of IFNg from splenic T cells was indicate that high amounts of IL-12 can induce Th1 cell
analyzed using ELISA. development in vitro in the absence of IL-18, although
(C) Naive splenic T cells were cultured for 4 days in the presence P. acnes± or BCG-infected IL-182/2 mice displayed im-
of 1000 U/ml of IL-4 in anti-CD3 antibody-coated plates. After 4
paired in vivo Th1 response.days of culture, T cells were washed and stimulated by immobilized
anti-CD3 antibody for 24 hr. The concentrations of IL-4 in culture
supernatants were measured using ELISA. IL-18 Enhanced NK Cell Activity in IL-122/2 Mice
(D) Naive splenic T cells were cultured for 4 days in the presence Although IL-182/2 mice displayed decreased IFNg pro-
of 2 ng/ml IL-12 in anti-CD3 antibody-coated plates. The production duction, impaired NK activity, and defective Th1 cell
of IFNg from the stimulated T cells was analyzed using ELISA.
response, these functions were not completely dis-
turbed. In addition, administration of high doses of IL-
12 restored the impaired NK cell activity, and in vitroto induce Th1 response in vivo (Okamura et al., 1982;
Matsui et al., 1997). Seven days after injection, splenic stimulation with IL-12 induced almost normal Th1 cell
development in IL-182/2 mice. Recently, IL-12 p40-defi-T cells were purified and stimulated with anti-CD3 anti-
body. At the 24 hr culture period, culture supernatants cient (IL-122/2) mice also showed partial impairment in
these functions (Magram et al., 1996a). To investigatewere analyzed for IFNg production by ELISA. Elevated
levels of IFNg production were observed in wild-type the role of IL-18 more precisely, we analyzed the effect
of exogenous IL-18 on NK cell activity seen in IL-122/2mice, while IFNg production from IL-182/2 T cells was
markedly reduced (Figure 4A). We next infected themice mice. As previously reported, NK cell activity in IL-122/2
mice was about two-thirds of that in wild-type micewith Mycobacterium bovis (bacillus Calmette-GueÂ rin
[BCG]), which is also known to induce IFNg production (Magram et al, 1996a). We intraperitoneally injected 10,
100, or 1000 ng of IL-18 daily for 2 days, and measuredin vivo (Kawamura et al., 1992), and assayed for IFNg
production. The IFNg production from IL-182/2 T cells NK lytic activity against YAC-1 target cells. In wild-type
mice, administration of IL-18 enhanced NK activity in awas about one third of that from wild-type T cells (Figure
4B). These results demonstrate that the in vivo Th1 cell dose-dependent manner (Figure 5). In contrast, 10 ng of
IL-18 didnot activateNK cells in IL-122/2 mice. However,response was impaired in IL-182/2 mice.
We studied in vitro differentiation of naive Th cells administration of 100 ng or 1000 ng of IL-18 to IL-122/2
mice resulted in almost the same enhancement of NKinto Th1 or Th2 cells. Naive splenic T cells were cultured
for 4 days in the presence of IL-12, which induces Th1 activity as in the wild-type mice (Figure 5). These results
indicate that IL-18 acts on NK cells in the absence ofcell differentiation, or in the presence of IL-4, which
induces Th2 cell differentiation. They were then restimu- IL-12.
We next examined in vitro activation of NK cells inlated with anti-CD3 antibody for 24 hr (Paul, 1991; Trin-
chieri, 1994, 1995). When T cells were cultured with IL- response to IL-12 or IL-18, using IL-122/2 or IL-182/2
mice. Spleen cells isolated from wild-type, IL-122/2, or4, production of IL-4 from both wild-type and IL-182/2
T cells was at almost the same level, indicating that Th2 IL-182/2 mice were cultured with IL-12 or IL-18 for 24
hr, and measured for cytolytic activity against YAC-1cell differentiation was not impaired in IL-182/2 mice
IL-18 Knockout Mice
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We finally analyzed Th1 cell development in BCG-
infected mice. As mentioned above, IL-182/2 showed
decreased Th1 response, the level of which was about
3-fold lower than that of wild-type mice. Th1 response
in BCG-infected IL-122/2 mice was reduced to about
one fourth of that in wild-type mice (Figure 7B). In the
case of IL-122/2IL-182/2 mice, IFNg production from
BCG-infected T cells was severely diminished, to a level
about 12-fold lower than that of wild-type mice (Figure
7B).
Thus, IL-122/2IL-182/2 mice displayed marked reduc-
tion in NK activity and severely impaired Th1 cell devel-
opment. These results clearly demonstrate that the co-
Figure 6. In Vitro Stimulation of NK Cells or Induction of Th1 Cell operative action of both IL-12 and IL-18 is essential for
Development by IL-18 in IL-122/2 Mice
activation of NK cells and induction of Th1 cell response
(A) Splenocytes from wild-type, IL-122/2, or IL-182/2 mice were incu-
in vivo.bated with IL-18 or IL-12 for 24 hr. Their NK activities against YAC-1
target cells were measured. The data are the activity at a 50/1 E/T
ratio. Discussion
(B) Splenic T cells from wild-type or IL-122/2 mice were cultured for
4 days in the presence of 2 ng/ml of IL-12 or 20 ng/ml of IL-18 in
In this study, we describe the generation and character-anti-CD3 antibody-coated plates. After 4 days of culture, T cells
ization of IL-182/2 mice. These mice developed normally,were washed and stimulated by immobilized anti-CD3 antibody for
were fertile, and showed no obvious signs of disease24 hr. The concentrations of IFNg in culture supernatants were mea-
sured by ELISA. until 28weeks of age, indicating that IL-18 is not involved
in normal mouse development. However, several immu-
nological defects were identified in IL-182/2 mice. Fur-cells (Figure 6A). NK activity of IL-182/2 cells, when incu-
thermore, generation of double-knockout mice lackingbated with IL-12 in vitro, was enhanced almost equally
IL-18 and IL-12 have revealed that the combined actioncompared with that of wild-type mice. Reciprocally,
of these cytokines plays a key role in NK activity as wellspleen cells from IL-122/2 mice showed almost the same
as in in vivo Th1 development.enhancement of NK lytic activity as those from wild-
type mice did after in vitro stimulation with IL-18. Thus,
in vitro study also demonstrates that IL-12 activates NK Defective IFNg Production in IL-182/2 Mice
cells in the absence of IL-18, and vice versa. Several in vitro studies have shown that IL-18 shares
In contrast, splenic T cells from wild-type or IL-122/2 biological properties with IL-12. These properties in-
mice did not differentiate into IFNg-producing Th1 cells clude the induction of IFNg production and the enhance-
by in vitro stimulation with IL-18, although in vitro stimu- ment of NK cell activity. However, the contribution of
lation with IL-12 induced almost normal Th1 cell devel- IL-18 to these functions in vivo has not been studied.
opment in IL-182/2 mice (Figures 4D and 6B). This is IL-12 has been described as the factor most responsible
consistent with the previous report stating that IL-18 in for IFNg production and Th1 cell development. IL-12
itself does not induce Th1 cell development (Matsui et exerts these functions together with several costimu-
al., 1997; Robinson et al., 1997). lants (Trinchieri, 1994, 1995). IFNg has been shown to
be one of the potent costimulants for IL-12 in the induc-
NK Cell Activity and Th1 Response in Mice tion of the Th1 response (Seder et al., 1993; Schmitt
Deficient in Both IL-12 and IL-18 et al., 1994). Recently, IL-12±deficient mice have been
Analysis of NK cell activity in IL-182/2 or IL-122/2 mice generated in order to examine the in vivo role of IL-12.
revealed that high amounts of IL-12 or IL-18 compen- In IL-12±deficient mice, defects in IFNg production and
sates for the deficiency of each cytokine. In addition, the Th1 response were observed, but these defects were
the impairments observed in IL-182/2 or IL-122/2 mice not complete (Magram et al., 1996a, 1996b). It was there-
were not complete. These findings prompted us to pro- fore expected that several other cytokines, including IL-
pose that the synergistic action of IL-12 and IL-18 leads
18, could contribute to the low level of IFNg production
to activation of NK cells and Th1 cell development in
and the remaining Th1 response observed in the ab-
vivo. Therefore, we next generated and characterized
sence of IL-12. Like IL-122/2 mice, IL-182/2 mice dis-
mice deficient in both the IL-12 and IL-18 genes (IL-
played reduced production of IFNg in vivo, although IL-
122/2IL-182/2 mice) to examine these functions more
12 was secreted almost normally after LPS challenge.precisely.
This finding demonstrates that IL-18 is also an importantIL-122/2IL-182/2 mice were viable and showed no
factor for IFNg production in vivo, and that IL-18 defi-overt developmental abnormality. We first measured NK
ciency cannot be compensated for by IL-12 and otherlytic activity of spleen cells from IL-122/2 and/or IL-182/2
cytokines.mice. Although about one third and two thirds levels of
NKactivities was observedin IL-182/2 and IL-122/2 mice,
Role of IL-18 in Th1 Cell Developmentrespectively, further decreased lytic activity was ob-
Although a severely impaired Th1 response was shownserved in IL-122/2IL-182/2 mice, indicating that the co-
in P. acnes±injected IL-182/2 mice, a weak Th1 responseoperative action of IL-12 and IL-18 is indispensable for
the in vivo activation of NK cells (Figure 7A). was still observed in BCG-infected IL-182/2 mice. In
Immunity
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Figure 7. NK Activity and Th1 Response in
IL-122/2IL-182/2 Mice
(A) Naive spleen cells from wild-type, IL-
182/2, IL-122/2, or IL-122/2IL-182/2 mice were
analyzed for NK lytic activity against 51Cr-
labeled YAC-1 cells. 51Cr-releases in superna-
tants of cultures at the indicated effector/
target (E/T) ratios were measured.
(B) Mice were intravenously injected with 2
mg of BCG. Fourteen days after injection,
splenic T cells were purified and stimulated
by immobilized anti-CD3 antibody for 24 hr.
The concentrations of IFNg in culture super-
natants were measured using ELISA.
addition, in vitro stimulation with IL-12 induced almost response may include IFNg itself (Szabo et al., 1997),
IFNa (Manetti et al., 1995; Rogge et al., 1997), IL-1a/bnormal Th1 cell development in IL-182/2 mice, indicating
that the presence of high concentrations of IL-12 is suffi- (Robinson et al., 1997), or an as yet unidentified factor.
Indeed, IL-18 acted on NK cells to produce IFNg thatcient for induction of the Th1 response in the absence
of IL-18. These findings appear to be consistent with may induce Th1 cell development in the absence of IL-
12 (H. T., unpublished data). These factors might alsoprevious reports showing that IL-12 is a key factor in
Th1 cell development and that IL-18 in itself does not contribute to the remaining Th1 response observed in
BCG-infected IL-122/2IL-182/2 mice. The present studyinduce the differentiation of naive Th0 cells into Th1
cells and acts only on IL-12±primed Th1 developing cells clearly demonstrates that the Th1 cell response can be
induced by IL-18 independently of IL-12, although IL-for IFNg production (Matsui et al., 1997; Robinson et al.,
1997). In addition, it is shown that IL-12±stimulated Th1 12 is a central factor in Th1 cell development.
cell lines exhibit enhanced binding capacity to IL-18
(Ahn et al, 1997). Our data demonstrate that naive Th
Both IL-12 and IL-18 Contribute to Functionalcells display increased mRNA expression of the IL-18
Development of NK Cells as well as toreceptor when stimulated with IL-12 (T. Y., unpublished
Their Activationdata).
The total cell number of splenic NK cells from IL-182/2,From these findings, the following scenario may be
IL-122/2, or IL-122/2IL-182/2 mice, as determined by theestablished: naive Th cells, when primed with IL-12,
CD32, IL-2Rb1 population, was almost the same as thatexpress the IL-18 receptor and then develop into fully
from wild-type mice, indicating that either IL-12 or IL-differentiated Th1 cells in response to both IL-12 and
18 is not involved in the early development of NK cellsIL-18. However, BCG-infected IL-122/2 mice displayed
(data not shown). However, NK activity of naive spleenan impaired but significant level of Th1 response. This
cells from either IL-122/2, IL-182/2, or IL-122/2IL-182/2demonstrates that naive Th cells actually develop into
mice was attenuated in this order, strongly suggestingTh1 cells in the absence of IL-12. Furthermore, IL-122/2
that both IL-12 and IL-18 are involved in the functionalIL-182/2 mice displayed more profound impairment in
maturation of NK cells.the Th1 response after BCG infection as compared with
Naive splenic T cells have no mRNA expression of theIL-122/2 or IL-182/2 mice. Thus, IL-18 deficiency affects
IL-18 receptor, whereas they come to express the IL-Th1 cell development in IL-122/2 mice, indicating that
18 receptor during Th1 cell development. In contrast,IL-18 accounts for Th1 cell development in vivo even in
splenic NK cells from wild-type mice are able to respondthe absence of IL-12. This result led us to thespeculation
to IL-18 and exert their facilitated killing activity againstthat IL-122/2 naive Th cells might acquire respon-
YAC-1 cells. Additionally, splenic NK cells freshly iso-siveness to IL-18 by expressing the IL-18 receptor inde-
lated from wild-type mice showed enhanced killing ac-pendently of IL-12 after BCG infection, and differentiate
tivity in response to in vitro stimulationwith IL-18 withoutinto Th1 cells in response to IL-18. Nevertheless, fully
any help from IL-12. These findings prompted us todifferentiated wild-type Th1 cells after BCG infection did
investigate whether endogenous IL-12 is mandatory fornot produce augmented levels of IFNg by in vitro stimu-
the up-regulating action of IL-18 on NK activity. As ex-lation with IL-18 alone. On the contrary, these T cells
pected, IL-18 augmented the NK activity of spleen cellsproduced a significant level of IFNg in response to IL-
from IL-122/2 mice, indicating that NK cells do not re-12 alone as well as a high level of IFNg by stimulation
quire any stimulation with IL-12 for the response to IL-with thecombination of IL-12 and IL-18 (data not shown).
18. Recently, we observed that splenic nonadherentThese results indicate that IL-12±independent Th1 cell
cells from SCID mice, lacking T cells or Bcells but havingdevelopment could be induced by the cooperative ac-
tion of IL-18 and other factors. These factors for Th1 intact NK cells, constitutively express the IL-18 receptor
IL-18 Knockout Mice
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24 hr. Concentration of IFNg or IL-4 in culture supernatants wasmRNA and produce IFNg in response to stimulation with
determined by ELISA.IL-18 (H. T., unpublished data). IL-12 also activates cyto-
lytic activity of spleen cells against YAC-1 cells indepen-
In Vivo Induction of Th1 or Th2 Cell Differentiation
dently of IL-18, because spleen cells from IL-182/2 mice, Mice were injected intraperitoneally with 500 mg of heat-killed P.
when stimulated in vitro with IL-12, had almost the same acnes to induce a Th1 response in vivo. Seven days after injection,
cytotoxic activity againstYAC-1 cellsas those from wild- splenic T cells were purified and stimulated on anti-CD3 antibody-
coated 96-well plates for 24 hr as described above. Level of IFNgtype mice. Thus, the action of IL-18 on NK cells does
in culture supernatants was determined by ELISA. In the case ofnot need intrinsic IL-12, and vice versa.
BCG infection, mice were injected intravenously with 2 mg of BCG
(Kyowa, Japan). Fourteen days after injection, splenic T cells were
Experimental Procedures purified and assayed for IFNg production, as described above.
Generation of IL-18±Deficient Mice
Analysis of NK Cell ActivityIL-18 genomic DNA was screened from an 129/SvJ mouse genomic
Naive spleen cells were incubated with 51Cr-labeled YAC-1 targetlibrary (Stratagene), subcloned into the pBluescript vector, and char-
cells at the indicated effector/target ratios. After 4 hr of culture,acterized by restriction enzyme mapping and DNA sequencing. A
supernatants were counted for 51Cr release by g counter. For admin-targeting vector was designed to replace a 3.0 kb genomic fragment
istration of IL-18 or IL-12, mice were intraperitoneally injected withcontaining exons 3, 4, and 5 with pMC1-neo (Stratagene). The tar-
PBS or the indicated doses of IL-18 or IL-12 daily for 2 days. Spleen
geting vector was flanked by the 5.2 kb fragment at the 39 end and
cells of these mice at day 3 were assayed for NK lytic activity against
the 1.0 kb fragment at the 59 end and contains a HSV-tk cassette 51Cr-labeled YAC-1 target cells.
at the 39 end of the vector. The targeting vector was linearized with
In the case of in vitro activation of NK cells, spleen cells wereSalI and electroporated into embryonic day 14.1 embryonic stem
incubated with or without 2 ng/ml IL-12 or 20 ng/ml IL-18 for 24 hr.cells. The resistant clones to G418 and gancyclovir were screened
Their cytolytic activity against YAC-1 cells was measured.for homologous recombination by polymerase chain reaction and
confirmed by Southern blot analysis with the probe shown in Figure
Acknowledgments1A. Generation of chimeric mice and mutant mice was essentially
as described previously (Takeda et al., 1997).
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